- Who Carries the Individual Duty to Report?
- Institutional Duty: RIOs, Named Persons and Responsible Officers
- Common Questions on Reporting Research Misconduct
- Whistle-Blower Protections: Reporting Without Retaliation
- Implications for Research Administrators and Institutions
- A Shared, Structured Duty
Search interest in “whose responsibility is it to identify and report research misconduct” spikes around research-ethics coursework and institutional training, but the confusion it reflects is real and consequential. The honest answer is that whose responsibility it is to identify and report research misconduct depends on the role: the duty is shared, not singular, and it is formalised differently in the UK and the US. Principal investigators, co-authors, supervisors, peer reviewers, editors and institutional officers each hold a piece of the obligation, and neither UK nor US frameworks let any one of these roles opt out.
This explainer sets out who owes a formal duty to report, which institutional office receives and manages that report, and what legal protection exists for the person who raises the concern.
Who Carries the Individual Duty to Report?
The starting point in both UK and US frameworks is that everyone involved in producing, reviewing or supervising research shares a duty of vigilance. A widely cited analysis of collaborative authorship, published in PMC (Helgesson et al., 2017), concludes that “every author shares the responsibility to be attentive to signs of misconduct” and is obliged to act if fraud or fabrication is suspected in a paper they co-author — co-authorship does not dilute individual accountability.
In practice, the individuals expected to identify and escalate concerns include:
- Principal investigators (PIs) — responsible for the conduct of their research programme and for acting on concerns raised by team members.
- Co-authors and collaborators — expected to query irregularities in data, methods or results before a manuscript is submitted or published.
- Supervisors of doctoral and early-career researchers — responsible for training on research standards and for reporting concerns about supervisees’ conduct.
- Peer reviewers and journal editors — obliged under Committee on Publication Ethics (COPE) guidance to raise suspected fabrication, falsification or plagiarism (FFP) identified during review, rather than simply rejecting the manuscript.
- Institutional Review Board / ethics committee members — responsible for flagging non-compliance with approved protocols.
None of these roles constitutes the sole responsible party. That is the most common misconception behind the search query: there is no single “correct” answer among a multiple-choice list of individuals, because UK and US institutional policy assign the duty collectively.
Institutional Duty: RIOs, Named Persons and Responsible Officers
Once an individual raises a concern, formal responsibility shifts to a designated institutional office. The terminology and statutory basis differ between the UK and US, though the underlying model — an initial assessment, followed by a full investigation panel with external academic input — is similar in both systems.
In the UK, the Concordat to Support Research Integrity (Universities UK, revised 2019) requires every signatory institution to have a published misconduct procedure and to designate a responsible individual — commonly titled the Named Person or Responsible Officer — to receive and triage allegations. UK Research and Innovation’s April 2025 guidance for research organisations goes further, requiring any organisation receiving UKRI funding to investigate allegations of research misconduct involving its staff or students, regardless of who funded the specific project in question. The UK Research Integrity Office (UKRIO) is not a statutory regulator; it is an independent advisory body that publishes a model procedure institutions can adopt or adapt.
In the US, the equivalent office is the Research Integrity Officer (RIO), a role every institution receiving Public Health Service funding must designate under 42 CFR Part 93. The federal Office of Research Integrity (ORI), within the Department of Health and Human Services, oversees PHS-funded misconduct activity, defines fabrication, falsification and plagiarism (FFP) in federal regulation, and can review institutional findings on appeal.
| Aspect | United Kingdom | United States |
|---|---|---|
| Sector-wide framework | Concordat to Support Research Integrity (Universities UK, rev. 2019) | 42 CFR Part 93 (HHS/PHS regulations) |
| Designated institutional role | Named Person / Responsible Officer | Research Integrity Officer (RIO) |
| Federal/national oversight body | None statutory; UKRIO advises, UKRI mandates investigation for its grantees | Office of Research Integrity (ORI), HHS |
| Core definition used | Fabrication, falsification, plagiarism and other serious deviations from accepted practice | Fabrication, falsification, plagiarism (FFP) per 42 CFR §93.103 |
| Whistle-blower statute | Public Interest Disclosure Act 1998 (amends Employment Rights Act 1996) | Retaliation protections built into 42 CFR Part 93 institutional assurances |
Common Questions on Reporting Research Misconduct
Who has the primary responsibility for investigating allegations of research misconduct?
The host institution holds primary investigative responsibility, not the individual who raises the concern. A designated officer — the Research Integrity Officer in the US or the Named Person in the UK — triages the allegation, and a panel including external academic members conducts the full investigation if warranted.
Who do you report research misconduct to?
Concerns should go to the institution’s designated contact — typically the Research Integrity Officer, Named Person, or a supervisor/department head who escalates it formally. Many institutions also run confidential ethics or research-integrity hotlines for concerns raised anonymously.
Who oversees research misconduct nationally?
In the US, the Office of Research Integrity oversees PHS-funded misconduct activity on behalf of HHS. In the UK, no single statutory regulator exists; UKRIO provides advisory guidance and a model procedure, while UKRI mandates investigation as a funding condition for its grantees.
What conduct counts as research misconduct under federal regulations?
US federal regulation (42 CFR Part 93) defines research misconduct as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting results. Honest error and legitimate differences of scientific opinion are explicitly excluded.
Whistle-Blower Protections: Reporting Without Retaliation
Fear of retaliation is the most cited reason researchers stay silent about suspected misconduct, so both jurisdictions build legal protection into the reporting pathway.
- UK: The Public Interest Disclosure Act 1998, which amends the Employment Rights Act 1996, protects workers who make a “protected disclosure” — including a reasonable belief that a legal obligation, such as a research or funding-body requirement, is being breached — from dismissal or detriment.
- US: Institutions holding PHS funding must provide, as a condition of their assurance under 42 CFR Part 93, protection for complainants and witnesses against retaliation, and must diligently protect confidentiality where feasible during the assessment and inquiry stages.
Institutional attribution practices also support accountability once an investigation is under way. Contributor role taxonomies used at submission — such as CRediT, which CASRAI originated in 2014 and which is now stewarded by NISO as ANSI/NISO Z39.104-2022 — make it easier for investigators to establish which named author was responsible for which specific contribution, rather than relying on blanket authorship credit. Research administrators building or reviewing misconduct procedures may find it useful to consult CASRAI’s overview of contributor role taxonomies and the individual CRediT roles alongside broader guidance on authorship standards.
Implications for Research Administrators and Institutions
For research administration offices, three practical implications follow from the shared-duty model:
- Policy visibility matters as much as policy existence. The Concordat requires institutions not just to have a procedure but to publicise it to staff and the public — a written policy that nobody can find fails the spirit of Commitment 4.
- Reporting channels need redundancy. Because responsibility is distributed across PIs, supervisors, co-authors and reviewers, a single named contact is not enough; institutions typically also need a confidential hotline route and a clear escalation path via department heads.
- Investigation and disciplinary process must stay separate. UKRIO and ORI guidance both stress that the misconduct investigation determines what happened; any resulting disciplinary action is a distinct, subsequent process, with its own procedural safeguards.
Institutions that receive UKRI funding should also note that the funder’s own guidance, updated in April 2025, requires investigation of allegations against staff or students as a condition of the funding relationship — independent of whether the specific allegation concerns a UKRI-funded project.
A Shared, Structured Duty
There is no single office or job title that owns research misconduct reporting end to end. Individual researchers — PIs, co-authors, supervisors and reviewers — carry a front-line duty to notice and escalate; a designated institutional officer (Research Integrity Officer in the US, Named Person or Responsible Officer in the UK) carries the duty to receive, triage and investigate; and national bodies (ORI in the US; UKRIO advisory guidance and UKRI funding conditions in the UK) set the framework both operate within. As funders sharpen their compliance requirements — UKRI’s April 2025 guidance being the most recent UK example — institutions should expect the expectation of distributed accountability, not a single responsible party, to keep hardening rather than simplifying.
